NO20005042D0 - FremgangsmÕter for Õ inhibere MRP1 - Google Patents

FremgangsmÕter for Õ inhibere MRP1

Info

Publication number
NO20005042D0
NO20005042D0 NO20005042A NO20005042A NO20005042D0 NO 20005042 D0 NO20005042 D0 NO 20005042D0 NO 20005042 A NO20005042 A NO 20005042A NO 20005042 A NO20005042 A NO 20005042A NO 20005042 D0 NO20005042 D0 NO 20005042D0
Authority
NO
Norway
Prior art keywords
methods
mrp1
inhibit
inhibit mrp1
Prior art date
Application number
NO20005042A
Other languages
English (en)
Other versions
NO20005042L (no
Inventor
Joseph Michael Gruber
Bryan Hurst Norman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005042D0 publication Critical patent/NO20005042D0/no
Publication of NO20005042L publication Critical patent/NO20005042L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005042A 1998-04-08 2000-10-06 FremgangsmÕter for Õ inhibere MRP1 NO20005042L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8107798P 1998-04-08 1998-04-08
PCT/US1999/007343 WO1999051227A1 (en) 1998-04-08 1999-04-07 Methods for inhibiting mrp1

Publications (2)

Publication Number Publication Date
NO20005042D0 true NO20005042D0 (no) 2000-10-06
NO20005042L NO20005042L (no) 2000-10-06

Family

ID=22161958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005042A NO20005042L (no) 1998-04-08 2000-10-06 FremgangsmÕter for Õ inhibere MRP1

Country Status (17)

Country Link
US (1) US6417193B1 (no)
EP (1) EP1069897A1 (no)
JP (1) JP2002510624A (no)
KR (1) KR20010042482A (no)
CN (1) CN1296408A (no)
AU (1) AU3468099A (no)
BR (1) BR9909497A (no)
CA (1) CA2327706A1 (no)
EA (1) EA200001036A1 (no)
HU (1) HUP0101736A3 (no)
ID (1) ID27048A (no)
IL (1) IL138391A0 (no)
NO (1) NO20005042L (no)
PL (1) PL343312A1 (no)
SK (1) SK15002000A3 (no)
TR (1) TR200002803T2 (no)
WO (1) WO1999051227A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743794B2 (en) 1999-12-22 2004-06-01 Eli Lilly And Company Methods and compounds for inhibiting MRP1
ES2233487T3 (es) * 1999-12-22 2005-06-16 Eli Lilly And Company Procedimientos y compuestos para la inhibicion de mrp1.
EP1301518A1 (en) 2000-06-14 2003-04-16 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
WO2002000624A2 (en) * 2000-06-23 2002-01-03 Eli Lilly And Company Methods and compounds for inhibiting mrp1
JP2004509897A (ja) * 2000-09-22 2004-04-02 イーライ・リリー・アンド・カンパニー シクロヘキシルアミン誘導体の立体選択的製造方法
WO2002081482A1 (en) * 2001-04-09 2002-10-17 Eli Lilly And Company Compounds and methods for inhibiting mrp1
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
CN104002843A (zh) * 2014-05-29 2014-08-27 安徽银龙泵阀股份有限公司 一种减震效果好易于放置的双泵移动车

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744485A (en) 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
US5717092A (en) * 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity

Also Published As

Publication number Publication date
SK15002000A3 (sk) 2001-06-11
WO1999051227A1 (en) 1999-10-14
TR200002803T2 (tr) 2000-12-21
IL138391A0 (en) 2001-10-31
EP1069897A1 (en) 2001-01-24
EA200001036A1 (ru) 2001-04-23
CN1296408A (zh) 2001-05-23
KR20010042482A (ko) 2001-05-25
PL343312A1 (en) 2001-08-13
US6417193B1 (en) 2002-07-09
HUP0101736A3 (en) 2002-04-29
ID27048A (id) 2001-02-22
HUP0101736A2 (hu) 2001-11-28
BR9909497A (pt) 2000-12-12
AU3468099A (en) 1999-10-25
CA2327706A1 (en) 1999-10-14
JP2002510624A (ja) 2002-04-09
NO20005042L (no) 2000-10-06

Similar Documents

Publication Publication Date Title
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
FI4209U1 (fi) Uusia yhdisteitä
NO20006114D0 (no) Nytt 3-aryl-2-hydroksypropionsyrederivat III
NO306826B1 (no) Anordning ved stigerör
NO20011403D0 (no) Terapi for Õ forbedre kongestion
ID29139A (id) Metode granulasi basah untuk menghasilkan granul-granul
ID27004A (id) Senyawa-senyawa kalsilitik
NO20006638L (no) Vannutskiller
ID25957A (id) Peralatan untuk memisahkan cairan padatan
NO20005023D0 (no) FremgangsmÕter for Õ hemme MRP1
DE69908679D1 (de) Verfahren zum Weitern
ID27048A (id) Metode untuk mencegah mrp1
NO20005041D0 (no) FremgangsmÕte for Õ inhibere MRP1
ID28356A (id) Turunam tiazola
NO20005148D0 (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
ID28433A (id) Turunan propenil sefalosporin
ATA135199A (de) Wasserrutschbahnen
DE59902712D1 (de) Gefache
NO20005269D0 (no) Vertikal tørke
NO20003460D0 (no) Meie for slede
SE9800510D0 (sv) New Compounds
SE9800512D0 (sv) New compounds
SE9803747D0 (sv) New compounds
SE9803746D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application